Formulary Chapter 21: Palliative Care Formulary - Full Chapter
|
|
Details... |
21 |
Palliative Care Formulary |
|
|
|
|
21.01.01.01 |
Non-opioid analgesics |
|
|
Paracetamol
(Oral)
|
First Choice

|
- Tablet 500mg
- Dispersible tablet 500mg
- Oral SuspensionSF 120mg/5ml, 250mg/5ml
- Suppository 60mg, 120mg, 240mg, 500mg, 1g
|
|
Ibuprofen
(Oral)
|
First Choice

|
- 200mg, 400mg and 600mg tablets
- Oral suspension
|
|
Ibuprofen
(Topical)
|
First Choice

|
- 100g gel containing 5% ibuprofen
- Fenbid brand is most cost effective
|
|
Naproxen
(Tablets)
|
Second Choice

|
- 250mg and 500mg tablets
- Oral suspension and effervescent tablets available
- No evidence for GI benefit of EC preparation - use standard tablets.
|
|
21.01.01.02 |
Opioid analgesics |
|
|
Morphine Sulphate M/R
(Zomorph®)
|
First Choice

|
- m/r capsule 10mg, 30mg, 60mg, 100mg, 200mg
- 12 hourly dosing
- Zomorph can be opened & contents administered in semi-solid food for patients with swallowing difficulties.
- Zomorph also licensed for use via gastric or gastronomy tubes (diameter >16F.G.).
- There is no evidence of superior clinical analgesic effect of other opioids over morphine.
|
|
Morphine Sulphate solution
(Oramorph®)
|
First Choice

|
- 10mg/5ml Schedule 5 (CD Inv)
- 100mg/5ml Schedule 2 (CD)
- 4 hourly dosing PRN
|
|
Morphine Sulphate
(Sevredol®)
|
First Choice

|
- 10mg,20mg,50mg immediate release tablets
- Sevredol® tablet - 4 hourly dosing
|
|
Oxycodone
(Longtec®)
(Modified Release tablets)
|
Second Choice

|
- M/R Tablets 5mg, 10mg, 20mg, 40mg, 60mg, 80mg Longtec®. Prescribe by brand.
- For the treatment of moderate to severe pain in patients with cancer pain.
- Oxycodone may be initiated in preference to morphine for the management of pain by a GP with experience in palliative care or on the advice of the palliative care team or pain team when: Dose escalation with morphine is not possible due to opioid toxicity eg. hallucinations, myoclonic jerks and confusion.
|
|
Oxycodone
(Shortec®)
(Oral)
|
Second Choice

|
- Tablets 5mg, 10mg, 20mg, Shortec®.
- Oral solution 5mg/5ml, or concentrate 10mg/ml
- Prescribe by brand.
- Oxycodone may be initiated in preference to morphine for the management of pain by a GP with experience in palliative care or on the advice of the palliative care team or pain team.
|
|
Buprenorphine
(7 day patch)
|
Formulary

|
- LOW STRENGTH PATCH
- 7 day patch of choice for consistency and safety
- Patch 5 microgram/hour for 7 days
- Patch 10 microgram/hour for 7 days
- Patch 15 micrograms/hour for 7 days
- Patch 20 microgram/hour for 7 days
- Only to be used in patients with cognitive deficit or swallowing difficulties, after a trial of soluble/liquid medication. Zomorph capsules can be opened up for ease of swallowing.
- Buprenorphine patches are NOT suitable, or licensed, for management of acute / intermittent pain.
- Patients and/or their carers neeed to be aware that these patches need to be applied at appropriate seven-day intervals. Remember to remove the old patch before application of new patch. Avoid use of multiple patches.
|
|
Codeine Phosphate
(Oral)
|
Formulary

|
- Tablet 15mg, 30mg, 60mg
- Useful for the relief of mild to moderate pain but is too constipating for long-term use
|
|
Buprenorphine
(4 day patch)
|
Formulary

|
- HIGH STRENGTH PATCH
- Patch 35 microgram/ hour, for 4 days
- Patch 52.5 microgram/ hour, for 4 days
- Patch 70 microgram/ hour, for 4 days
- Only to be used in patients with cognitive deficit or swallowing difficulties, after a trial of soluble/liquid medication. Zomorph capsules can be opened for ease of swallowing.
- Buprenorphine patches are not suitable for management of acute / intermittent pain.
- Patients and/or their carers need to be aware that these patches need to be applied at appropriate 96 hour intervals (or 4 days). Remember to remove the old patch before application of new patch. Avoid use of multiple patches.
|
|
Tramadol
(Oral)
|
Formulary

|
- Capsules 50mg
- Soluble tablets 50mg
- Modified release MR capsules (limited use)
- Schedule 3 CD with exemption from safe custody requirements
|
|
Fentanyl
(3 day Patch)
|
Formulary

|
- 12microgram/hour, for 3 days
- 25microgram/hour, for 3 days
- 50microgram/hour, for 3 days
- 75microgram/hour, for 3 days
- 100microgram/hour, for 3 day
- Fentanyl patches are only licensed for chronic intractable pain. For palliative care use.
- Fentanyl patches are not suitable for use in the management of acute / intermittent pain.
- Only to be used in patients who require equivalent dose of at least 60mg morphine daily
- Fentanyl is available both as a reservoir patch and a matrix patch (do not cut either)
- Patients and/or their carers need to be aware that fentanyl patches need to be applied at appropriate 72-hour (three-day) intervals. Remember to remove the old patch before application of new patch
- For dose conversion see BNF link below
|
•MHRA Drug Safety Update Oct 2018 | Transdermal fentanyl “patches”: reminder of potential for life-threatening harm from accidental exposure, particularly in children
BNF opiate conversion information
|
Fentanyl
(buccal tablets)
|
Formulary

|
- 100micrograms, 200micrograms, 400micrograms, 600micrograms, 800micrograms
- Breakthrough cancer pain for patients in whom oral morphine sulphate solution is inappropriate. Under the recommendation of a palliative care specialist only.
- NOT approved for non cancer pain
- Patients must be assessed by the palliative care or pain team before commencing treatment. They should be used in the minority of patients with breakthrough pain that fail immediate release morphine or oxycodone. Review weekly.
- Prescribe by brand name to ensure that the correct product is dispensed.
|
|
Fentanyl
(sublingual tablets)
|
Formulary

|
- 100micrograms, 200micrograms, 300micrograms, 400micrograms, 600micrograms, 800micrograms
- Palliative care or pain specialist initiation only
- Patients must be assessed by the palliative care or pain team before commencing treatment. They should be used in the minority of patients with breakthrough pain that fail immediate release morphine or oxycodone. Review weekly.
|
|
Methadone
(Oral)
|
Formulary

|
- Tablets 5mg
- Oral Solution 1mg/ml
- Only on recommendation of palliative care specialist
|
|
21.01.01.03 |
Neuropathic Pain |
|
|
Amitriptyline
(Tablet)
|
First Choice

|
- Tablet 10mg, 25mg, 50mg
- 'Off label' use for neuropathic pain
|
|
Duloxetine
(Capsule)
|
Formulary

|
- Capsules 30mg, 60mg
- For the treatment of neuropathic pain
|
|
Pregabalin
(Capsule)
|
Formulary

|
- Capsules 25mg, 50mg, 75mg, 100mg, 150mg, 225mg, 200mg, 300mg
- Note pregabalin tablets are not included on the BSWformulary
- For neuropathic pain
Schedule 3 CD
|
Controlled drugs use regulations
|
Gabapentin
(Capsule)
|
Formulary

|
- Capsules 100mg, 300mg, 400mg
Schedule 3 CD
|
Controlled drugs use regulations
|
Nortriptyline
(Tablets)
|
Formulary

|
- Tablets 10mg, 25mg
- 'Off label' use for neuropathic pain
- Should only be used if amitriptyline isn't tolerated or is contra indicated
|
|
21.01.01.04 |
Bone pain / Other Pain |
|
|
Ibuprofen
(Oral)
|
First Choice

|
- 200mg, 400mg and 600mg tablets
- Oral suspension
|
|
Ibuprofen
(Topical)
|
First Choice

|
- 100g gel containing 5% ibuprofen
- Fenbid brand is most cost effective
|
|
Paracetamol
(Oral)
|
First Choice

|
- Tablet 500mg
- Dispersible tablet 500mg
- Oral SuspensionSF 120mg/5ml, 250mg/5ml
- Suppository 60mg, 120mg, 240mg, 500mg, 1g
|
|
Naproxen
(Tablets)
|
Second Choice

|
- 250mg and 500mg tablets
- Oral suspension and effervescent tablets available
- No evidence for GI benefit of EC preparation - use standard tablets.
|
|
Dexamethasone
(Oral)
|
Formulary

|
- For specific indications
- Tablets 500 microgram, 2mg
|
|
Diazepam
(Oral)
|
Formulary

|
- Tablets 2mg, 5mg, 10mg
- Oral Solution 2mg in 5ml,
CD Benz POM
|
|
Lidocaine
(plaster 5%)
|
Formulary

|
- Can be used as per Palliative Care specialist recommendation (off-label) on a case by case basis between specialist and GP. Locally agreed indication (August 2019).
- For all other indications see entry under neuropathic pain 04.07.03
- Medicated plasters lidocaine 5%. Prescribe by the brand name: Ralvo®
|
BSW Lidocaine Plaster guidance
Items which should not routinely be prescribed in primary care guidance for CCGs
|
Zoledronic Acid
(IV infusion)
|
Formulary

|
- 800 micrograms/ml, 5ml (4mg) vial
- Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone.
- Treatment of adult patients with tumour-induced hypercalcaemia (TIH).
|
|
|
Cyclizine
(Tablet)
|
Formulary

|
|
|
Domperidone
(Oral)
|
Formulary

|
- Tablet 10mg
- Suspension 5mg in 5ml
- Domperidone should be used at the lowest effective dose for the shortest possible duration
- Recommended adult dose for GI pain in palliative care is 10mg TDS. Higher doses should only be considered under specialist palliative care services.
|
BSW Domperidone Guidance
MHRA Drug Safety Update (Dec 2019): Domperidone for nausea and vomiting: lack of efficacy in children; reminder of contraindications in adults and adolescents
MHRA Drug Safety Update Dec 2014: Domperidone: risks of cardiac side effects
|
Haloperidol
(Oral)
|
Formulary

|
- Tablets 500 micrograms, 1.5mg, 5mg, 10mg
- Oral liquidSF 1mg in 1ml
|
|
Levomepromazine
(Tablet)
|
Formulary

|
- 25mg Tablets
- For palliative care for the management of pain, associated restlessness, distress or vomiting
|
|
Metoclopramide
(Oral)
|
Formulary

|
- Tablet 10mg
- Syrup 5mg in 5ml
- Metoclopramide and prochlorperazine are associated with a high risk of dystonias and oculogyric crises particularly in children, young adults and elderly.
- Severe reactions to metoclopramide should be treated with procyclidine injection
|
MHRA DSU Dec 2014 Metoclopramide: risk of neurological adverse effects
|
Ondansetron
(Oral)
|
Formulary

|
- Tablet 4mg, 8mg
- SyrupSF 4mg in 5ml
|
|
Prochlorperazine
(Oral)
|
Formulary

|
- Tablet 5mg
- Syrup 5mg in 5ml
- Buccal tablet 3mg (as an alternative to injection in Primary Care)
- Notes: Severe reactions to prochlorperazine should be treated with procyclidine injection, Prochlorperazine should not be prescribed for patients with Parkinson's & should be used with caution in the elderly.
|
|
Olanzapine
(oral)
|
Formulary

|
- Orodispersible tablet (Velotab®) 5mg
- For Nausea and Vomiting
|
|
21.01.03 |
Antisecretory drugs |
|
|
Hyoscine Butylbromide
(Tablet )
|
Formulary

|
|
MHRA Drug Safety Update (Feb 2017): Hyoscine butylbromide injection & risk of serious adverse effects in patients with underlying cardiac disease
|
Hyoscine Hydrobromide
(Tablets, patches, sublingual tablets)
|
Formulary

|
- 150mcg tablet
- 300mcg sublingual tablets
- Scopoderm® TTS Patch 1mg/ 72hrs
|
|
21.01.04 |
Anticonvulsants / Anxiolytics |
|
|
Diazepam
(Oral)
|
Formulary

|
- Tablets 2mg, 5mg, 10mg
- Oral Solution 2mg in 5ml,
CD Benz POM
|
|
Lorazepam
(Tablets)
|
Formulary

|
- Tablets 1mg
- Can be given subligually (off label)
- Not all brands of lorazepam can be absorbed sublingually. Please use Genus, Metwest and Genesis brands
CD Benz POM
|
|
Midazolam Maleate
(Epistatus®)
(Buccal)
|
Formulary

|
- Epistatus® Oromucosal solution prefilled single syringe 10mg/1ml
- Epistatus® Oromucosal solution 10mg/ml prefilled syringes: 2.5mg/0.25ml, 5mg/0.5ml, 7.5mg/0.75ml, (unlicensed). Individually wrapped in a pack of 4.
- Prescribe by BRAND (NB Buccolam brand is a different salt, STRENGTH and volume)
- In the palliative care setting PRN use only
|
|
|
Naloxegol
(Tablet)
|
Formulary

|
- 12.5mg & 25mg tablets.
- Please note: This may be considered as an option for treatment of opioid- induced constipation in adults, whose constipation has failed to adequately respond to laxatives appropriately escalated in accordance with our BSW Guidance on the Management of Constipation in Adults (2018), and in whom stopping opiates would be clinically inappropriate.
|
BSW Guidance on the Management of Constipation in Adults (2018)
NICE TA345: Naloxegol for treating opioid‑induced constipation
|
Methylnaltrexone
(Injection)
|
Formulary

|
- 12 mg/0.6 mL
- Opioid induced constipation in terminal illness when response to other laxatives inadequate.
- Formulary status under review
|
|
21.01.06 |
Miscellaneous or Other |
|
|
Antacid and Oxetacaine
(Suspension)
|
Unlicensed

|
- Oxetacaine 10mg/5ml with aluminium and magnesium hydroxides Suspension
- For palliative care use
|
|
21.02 |
Injectable Drugs including those which may be given by CSI via a Syringe Drivers |
|
|
21.02.01 |
Analgesic Injectable Drugs |
|
|
Morphine
(Injection)
|
First Choice

|
- For pain
- 5mg/5ml, 10mg/ml, 15mg/ml, 20mg/ml, 30mg/ml
- Can be used in syringe drivers
- If eGFR known to be less than 30 mL/min please liaise with specialist palliative care
- See page 89/90 Wessex Palliative Care Handbook (link at start of chapter)
|
|
Oxycodone
(Injection)
|
Second Choice

|
- For palliative care use, specialist initiation
- 10mg/ml, 20mg/2ml, (ONLY on specialist advice prescribe 50mg/1ml)
|
|
Diamorphine
(Injection)
|
Formulary

|
- Currently unavailable (March 2020)
- Use Morphine first line in syringe drivers
- For pain
- 5mg, 10mg, 30mg
- Can be used in syringe drivers
- See page 89/90 Wessex Palliative Care Handbook (link at start of chapter)
|
|
Diamorphine
(Injection)
|
Formulary

|
- Currently unavailable (March 2020)
- Use Morphine first line in syringe drivers
- For pain relief
- 100mg and more in a syringe driver (where low volume required) on advice of palliative care specialist
|
|
Diclofenac
(Injection)
|
Formulary

|
- 75mg in 3ml injection
- As recommended by palliative care specialists
- Can be used in syringe drivers
- See page 89/90 Wessex Palliative Care Handbook (link at start of chapter)
|
|
Fentanyl
(Injection)
|
Formulary

|
FOR BaNES Patients ONLY on specialist recommendation
- 100 micrograms in 2ml amp
-
Can be used in syringe drivers for in patients with renal impairment and an eGFR <30ml/min/1.73m2 or declining renal function on the advice of specialist palliative care service.
-
See page 89/90 Wessex Palliative Care Handbook (link at start of chapter)
|
|
Alfentanil
(injection)
|
Formulary

|
Alfentanil is only included on the BSWformulary for palliative care use in primary care when prescribed in SWINDON under specialist recommendation (AMBER TLS).
SAFETY NOTE - Alfentanil is a potent opioid anaesthetic agent that has a lower analgesic potency than fentanyl, but a much more rapid onset of action. Peak analgesic and respiratory depressant effects occur within 90 seconds. Use care when prescribing to ensure the dose is correct as severe harm and death has occurred from dose errors.
Preparations available:
- 500micrograms in 1mL (available as 1mg/2ml and 5mg/10ml ampoules)
- 5mg in 1ml (THIS IS TEN TIMES THE STRENGTH OF PREPARATION ABOVE. This higher strength preparation will not be widely stocked in clinical settings)
All alfentanil preparations are RED TLS drugs in Wiltshire ans BaNES.
|
|
Ketorolac
(injection)
|
Formulary

|
GWH Only
- 30mg in 1ml amp
- GWH: ONLY for specialist initiation and ongoing prescription by the Palliatve Care team, for the treatment of neuropathic cancer pain and bone pain in palliative care patients by sc injection / sc infusion (off-label use).
|
|
21.02.02 |
Antiemetic Injectable Drugs |
|
|
Metoclopramide
(Injection)
|
Formulary
|
- 100mg/20ml, 10mg in 2ml
- Metoclopramide and prochlorperazine are associated with a high risk of dystonias and oculogyric crises particularly in children, young adults and the elderly. Severe reactions to metoclopramide should be treated with procyclidine injection
|
MHRA DSU Dec 2014 Metoclopramide: risk of neurological adverse effects
|
Cyclizine
(Injection)
|
Formulary

|
- For nausea and vomiting
- 50mg/ml
- Can be used in syringe drivers check compatibility
- See page 89/90 Wessex Palliative Care Handbook (link at start of chapter)
|
|
Dexamethasone
(Injection)
|
Formulary

|
- 3.32 mg of dexamethasone (dexamethasone base) in 1 ml solution for injection which is equivalent to 4 mg dexamethasone phosphate (or 4.3 mg dexamethasone sodium phosphate)
- For use in syringe pumps following advice from palliative care specialists
- See page 89/90 Wessex Palliative Care Handbook (link at start of chapter)
|
|
Haloperidol
(Injection)
|
Formulary

|
- 5mg/ml
- For hallucinations and agitation and opioid induced nausea
|
|
Levomepromazine
(Injection)
|
Formulary

|
- For nausea and vomiting
- 25mg/ml
- Can be used in syringe drivers
- See page 89/90 Wessex Palliative Care Handbook (link at start of chapter)
|
|
Prochlorperazine
(Injection)
|
Formulary

|
- 12.5mg/1ml
- Notes: Severe reactions to prochlorperazine should be treated with procyclidine injection, Prochlorperazine should not be prescribed for patients with Parkinson's & should be used with caution in the elderly.
|
|
Ondansetron
(Injection)
|
Formulary

|
|
|
21.02.03 |
Antisecretory Injectable Drugs |
|
|
Glycopyrronium Bromide
(injection)
|
Formulary

|
- 200 micrograms in 1ml amp
- 600 micrograms in 3ml amp
- As an alternative to hyoscine butyl bromide for respiratory tract secretions
- Can be used in syringe drivers
- See page 89/90 Wessex Palliative Care Handbook (link at start of chapter)
|
|
Hyoscine Butlybromide
(Injection)
|
Formulary

|
- For respiratory tract secretions
- 20mg/ml
- For colic/reduce secretions in inoperable bowel obstruction
- See SPS website for Stock shortages
- Can be used in syringe drivers
- See page 89/90 Wessex Palliative Care Handbook (link at start of chapter)
|
|
Hyoscine Hydrobromide
(Injection)
|
Formulary

|
- Injection 400mcg/ml
- For respiratory tract secretions
- Can be used in syringe drivers
- See page 89/90 Wessex Palliative Care Handbook (link at start of chapter)
|
|
Octreotide
(Short acting Injection)
|
Formulary

|
- 50microgram/1ml, 100microgram/1ml
- For the short term management of high output stomas and fistulas and bowel obstructions
- Octreotide is best administered in a separate syringe driver. Please phone palliative care advice lines before mixing in a syringe driver.
|
|
Ranitidine
(Injection)
|
Formulary

|
- 50mg/2ml
- For use following advice of palliative care teams
- Can be used in syringe drivers
- See page 89/90 Wessex Palliative Care Handbook (link at start of chapter)
|
|
21.02.04 |
Anticonvulsant / Anxiolytic Injectable Drugs |
|
|
Midazolam
(Injection)
|
Formulary

|
- 10mg/2ml
- For restlessness, anxiety and agitation
- Can be used in syringe drivers
- See page 89/90 Wessex Palliative Care Handbook (link at start of chapter)
Schedule 3
|
|
Haloperidol
(Injection)
|
Formulary

|
- 5mg/ml
- For hallucinations and agitation
|
|
Levomepromazine
(Injection)
|
Formulary

|
- For nausea and vomiting
- 25mg/ml
- Can be used in syringe drivers
- See page 89/90 Wessex Palliative Care Handbook (link at start of chapter)
|
|
Levetiracetam
(Intravenous infusion)
|
Formulary

|
- 100mg/ml 5ml vial
- For use in syringe pumps following advice of palliative care specialists
- To be used an alternative to midazolam for the treatment of seizures where sedation is not desirable.
- Can be used in syringe drivers if patient on longterm oral levetiracetam.
- Can be used in syringe drivers
- See page 89/90 Wessex Palliative Care Handbook (link at start of chapter)
|
|
21.03 |
Just In Case Prescribing Primary Care |
|
|
|
Just in Case Bags / Box formalise anticipatory prescribing at the end of life, and can minimise distress to the patient and their family, should there be a sudden deterioration when medications are not easily accessible.
The prescriber should ensure that all relevant agencies are informed that the Just in Case Bag / Box is within the care setting. The patient must be reviewed within 24 hours of medication being administered from the bag. The Just in Case Bag / Box prescription should be reviewed every 4 weeks |
|
Morphine
(Injections 10mg /ml)
|
Formulary

|
- Community Just In Case Boxes
- For pain
- Use first line
|
|
Cyclizine
(Injection 50mg/ml)
|
Formulary

|
- Community Just In Case Boxes
- For nausea and vomiting
|
|
Diamorphine
(Injections 10mg /ml)
|
Formulary

|
- Current supply issues - use Morphine first line
- Community Just In Case Boxes
- For pain
|
|
Haloperidol
(Injection 5mg/ml )
|
Formulary

|
- Community Just In Case Boxes
- For hallucinations and agitation
|
|
Hyoscine Butylbromide
(Injection 20mg/ml )
|
Formulary

|
- Community Just In Case Boxes
- For respiratory tract secretions
- For colic/reduce secretions in inoperable bowel obstruction
|
|
Hyoscine Hydrobromide
(Injection 400mcg/ml)
|
Formulary

|
- Community Just In Case Boxes
- For respiratory tract secretions
|
|
Levomepromazine
(Injection 25mg/ml)
|
Formulary

|
- Community Just In Case Boxes
- For nausea and vomiting
|
|
Midazolam
(Injection 10mg/2ml )
|
Formulary

|
- Community Just In Case Boxes
- For restlessness, anxiety and agitation
|
|
21.04 |
Just In Case Prescribing by Secondary Care |
|
|
|
‘Just in case’ (JIC) medication for patients transferring out of the RUH
The Specialist Palliative Care Team in the RUH are keen to improve the quality of transfer of patients who wish to die in their own home or nursing home. Part of this is to ensure that patients have access to ‘just in case’ (JIC) medication if needed soon after leaving hospital. There are clear procedures in place in the community for this, but it is best practice for the staff most recently involved in the care to take responsibility for ensuring the following is in place:
- The patient wishes to be at home
- It is anticipated that they may deteriorate quickly and do not already have JIC medication in their home or nursing home
- Medication supplied in a pack with syringes and needles and a prescription / administration form signed by the hospital doctor that is valid for up to 7 days for community staff – this will allow medication to be given if needed prior to the community procedure being put in place
- Morphine supplied for JIC and in syringe driver if in place on transfer
For patients who are transferring home for care towards the end of life, but are not anticipated to deteriorate quickly, it is suggested that the community follow their own procedure for JIC medication. If anyone has any concerns, wants further information or wishes to provide feedback please contact: RUH Specialist Palliative Care Team, 01225 825567. For documents relating specifically to RUH Just In Case follow link
|
|
21.05 |
Useful contact details |
|
|
|
Name
|
Number
|
Dorothy House Hospice (8.30am-5pm)
|
01225 722988
|
24 hour Advice Line & Inpatient Unit
|
0345 0130 555
|
Hospice at Home Service
|
01225 722921
|
Royal United Hospital (RUH)
|
01225 428331
|
Palliative Care Team Office
|
01225 825567
|
Palliative Care Team Co-ordinator
|
01225 825749
|
Palliative Care Nurse Specialists
|
Bleeps 7529, 7615
|
RUH Oncology Services
|
|
Acute Oncology Office
|
01225 826362
|
Chemotherapy Suite
|
01225 825984
|
William Budd Day Unit
|
01225 824132
|
Satellite Pharmacy (chemo drug enquiries)
|
01225 825627
|
Prospect Hospice 24 hour advice line:
|
01793 816109
|
Salisbury Hospice 24 hour advice line:
|
01722 425113
|
|
|
21.06 |
Community Pharmacy Emergency Drugs List & Contact Details |
|
|
|
The table below lists BaNES/Swindon/Wilts community pharmacies that routinely hold the Emergency Medicines stock subject to replenishment and availability. Please note the Emergency Medicines stock lists vary slightly for the three areas – scroll down for more detail.
Please also consider calling your closest pharmacy first which may also hold Emergency or End of Life medicines. Click here for contact details of all pharmacies.
Details of BaNES pharmacies keeping Emergency Medicines
|
Boots Southgate, The Southgate Centre, Bath, BA1 1AT
|
01225 461251
|
Clements, 7 The Street, Radstock, BA3 3PL
|
01761 434687
|
LloydsPharmacy, 54 High Street, Keynsham, BS31 1DX
|
0117 9863678
|
LloydsPharmacy inside Sainsbury Green Park, Green Park Station, Bath, BA1 2DR
|
01225422740
|
Midsomer Pharmacy, 98 High Street, Midsomer Norton, BA3 2DE
|
01761 568202
|
LloydsPharmacy, The Avenue, Combe Down, Bath, BA2 5EG
|
01225 833195
|
LloydsPharmacy, St Chad's Surgery, Gullock Tyning, Midsomer Norton, BA3 2UH
|
01761 412249
|
LloydsPharmacy, Elm Hayes Health Centre, Clandown Road, Paulton, BS39 7SF
|
01761 412146
|
Day Lewis Pharmacy,493 Bath Road, Saltford BS31 3HQ
|
01225 874454
|
Lloyds Pharmacy, Keynsham Health Centre, St Clements Road, Keynsham, BS31 1AG
|
0117 986 4578
|
Details of Wiltshire pharmacies keeping Emergency Medicines
|
Asda Pharmacy Bradford Road Melksham Wiltshire SN12 8LQ
|
01225 491400
|
Boots the Chemist Unit 4, Gateway Centre Bythesea Road Trowbridge Wiltshire BA14 8FZ
|
01225 752068
|
Lloyds Pharmacy Hathaway Medical Centre Chippenham Wiltshire SN14 6GT
|
02476 432442
|
Pharmacy at Northlands 30-32 North Street Calne Wiltshire SN11 0HH
|
01249 812889
|
Tesco In-Store Pharmacy Tesco Stores Ltd Bourne Centre Southampton Road Salisbury Wiltshire SP1 2NY
|
0345 677 9592
|
The Pharmacy Drummer Lane Tidworth Wiltshire SP9 7FH
|
01980 843368
|
Boots Pharmacy Primary Care Centre Priory Way Burton Hill Malmesbury Wiltshire SN16 0FB
|
01666 826115
|
Morrisons Pharmacy 15-16 Estcourt Street Devizes Wiltshire SN10 1LA
|
01380 720615
|
Details of Swindon pharmacies keeping Emergency Medicines
|
Lloyds Pharmacy Unit 1 Royston Road, Park South, Swindon, SN3 2GD
|
01793 521379
|
Jephson, Wroughton health Centre, Barret Way, Wroughton, SN4 9LW
|
01793 812250
|
Hawthorn Pharmacy, 261 Cricklade Road, Swindon, SN2 1AE
|
01793 522430
|
Emergency Drug List for BANES [*note new additions April 2020]
Drug
|
Strength & Form
|
Quantity
|
Buprenorphine ( Butec®) [*new]
|
5mcg patch
|
2 x 4
|
Buprenorphine ( Butec®)
|
10mcg patch
|
2 x 4
|
Buprenorphine ( Butec®) [*new]
|
20mcg patch
|
1 x 4
|
Cyclizine
|
50mg/ml injection
|
3 x 5
|
Cyclizine
|
50mg tabs
|
1 x 100
|
Dexamethasone sodium phosphate
|
3.3mg/ml injection
|
1 x 10
|
Diamorphine
|
5mg injection
|
1 x 5
|
Diamorphine
|
10mg injection
|
2 x 5
|
Diamorphine
|
30mg injection
|
2 x 5
|
Diazepam Rectal Tubes (stesolid)
|
10mg
|
1 x 5
|
Diclofenac sodium
|
100mg suppositories
|
1 x 10
|
Fentanyl TTS (Mezolar® )
|
12mcg/hour
|
1 x 5
|
Fentanyl TTS (Mezolar®)
|
25mcg/hour
|
1 x 5
|
Fentanyl TTS (Mezolar®)
|
50mcg/hour
|
1 x 5
|
Glycopyrronium
|
200 microgram/ml inj.
|
1 x 10
|
Haloperidol
|
5mg/1ml injection
|
1 x 5
|
Haloperidol
|
500mcg capsules
|
1 x 30
|
Hyoscine Butylbromide (Buscopan)
|
20mg/ml injection
|
1 x 10
|
Hyoscine (scopaderm) [*new]
|
1.5mg patch
|
3x 2
|
Konakion MM (vitamin K injection)
|
10mg/ml – 1ml ampoules
|
1 x 10
|
Konakion MM Paediatric (vit k inj)
|
10mg/ml – 0.2ml ampoules
|
1 x 10
|
Lorazepam [*new]
|
1mg tablets ((ideally blue tablets or Metwest/Genesis brand )
|
3x28
|
Levomepromazine
|
25mg tablets
|
1 x 84
|
Levomepromazine NEW 2018
|
25mg/ ml injections
|
1 x 10
|
Metoclopramide
|
10mg/2ml
|
1 x 10
|
Midazolam
|
10mg/2ml injections
|
2 x 10
|
Morphine Sulphate
|
10mg/1ml injection ampoules
|
1 x 10
|
Morphine Sulphate (Zomorph)
|
10mg, 30mg and 100mg
|
1 x 60
|
Morphine Sulphate (Oramorph)
|
10mg/5ml
|
1 x 100
|
Morphine Sulphate concentrate (Oramorph)
|
20mg/ml liquid
|
1 x 120
|
Olanzapine (Orodispersible) [*new]
|
5mg tablets
|
3x28
|
Oxycodone HCl
|
10mg/ml 1ml
|
1 x 5
|
Oxycodone HCl
|
20mg/ 2ml
|
1 x 5
|
Sodium Chloride 0.9%
|
10ml injection
|
2 x 10
|
Sodium Chloride 0.9%
|
0.9% infusion 1L
|
1 x 10
|
Water for injections (Steriamps/miniplasco)
|
10ml injection
|
2 x 10
|
Oseltamivir (Tamiflu) [Oct to May]
|
30mg, 45mg, 75mg capsules
|
2x10
|
Oseltamivir (Tamiflu) [Oct to May]
|
6mg/1ml Suspension
|
1x65mL
|
Zanamivir (Relenza) [Oct to May]
|
5mg/ blister
|
1 x 5 Disks
|
Swindon area Emergency Drugs list for community pharmacies
|
|
Drug
|
Quantity
|
Cyclizine 50mg/ml Inj
|
30x1ml
|
Dexamethasone 4mg/ml Inj
|
10x2ml
|
Diamorphine 10mg inj
|
10
|
Diamorphine 30mg inj
|
10
|
Diamorphine 100mg inj
|
10
|
Diazepam 5mg/ml Inj
|
10x2ml
|
Glycopyrronium Bromide 200mcg/ml inj
|
30x1ml
|
Haloperidol 5mg/ml inj
|
5x2ml
|
Hyoscine Butylbromide 20mg/ml inj
|
30x1ml
|
Levomepromazine (Methotrimeprazine)25mg/ml inj
|
10x1ml
|
Metoclopramide 5mg/ml inj
|
12x2ml
|
Midazolam 2mg/ml inj
|
30x5ml
|
Octreotide 50mcg/ml inj
|
5x1ml
|
Octreotide 100mcg/ml
|
5x1ml
|
Sodium chloride 0.9% inj
|
10x10ml
|
Water for injection
|
30x10ml
|
Diclofenac 100mg Suppositories
|
10
|
Oramorph Oral Solution 10mg/5ml
|
1x100ml
|
Oramorph Concentrated Oral Solution 100mg/5ml
|
1x30ml
|
Morphine sulphate 10mg/ml inj
|
3x5
|
Morphine sulphate 15mg/ml inj
|
3x5
|
Morphine sulphate 30mg/ml inj
|
3x5
|
Oxycodone 10mg/ml 2ml inj
|
3x5
|
Oxycodone liquid 5mg/5ml
|
1x250ml
|
Oxycodone concentrate 10mg/ml
|
1x120ml
|
Fentanyl 12 Patch
|
1x5
|
Fentanyl 25 Patch
|
1x5
|
Fentanyl 75 Patch
|
1x5
|
Fentanyl 100 Patch
|
1x5
|
Naloxone 1mg/1ml in a 2ml syringe.
|
1 syringe
|
Midazolam oromucosal solution 10mg/1ml pre-filled syringes
|
2x1
|
Additions:
|
|
Buprenorphine patch 5mg
|
2x4
|
Buprenorphine patch 10mg
|
2x4
|
Methadone 1mg/ml oral solution
|
1x500ml
|
Oxycodone 50mg/ml injection
|
3x5
|
Alfentanil 1mg/2ml
|
1x10
|
Ondansetron 8mg/4ml injection
|
1x5
|
Tranexamic acid injection 500mg/5ml
|
1x10
|
Adrenaline 1mg/ml, 1 in 1000 x 10ml
|
1x10
|
Lorazepam 1mg tablets (ideally blue tablets or Metwest/Genesis brand )
|
3x28
|
Hyoscine 1.5mg patches
|
3x2
|
Orodispersible olanzapine 5mg tablets
|
3x28
|
Wiltshire area Emergency Drugs list for community pharmacies
|
|
|
Drug
|
Quantity
|
|
Ceftriaxone Injection 250mg
|
2x1
|
|
|
|
Alfentanil 500mcg/ml (1mg/2ml) (Rapifen)
|
10x2ml
|
|
|
|
Cyclizine 50mg/ml Inj
|
10x1ml
|
|
|
|
Cyclizine 50mg tabs
|
1x100
|
|
|
|
Dexamethasone 3.8mg/ml
|
10x1ml
|
|
|
|
Diazepam 10mg/2.5ml Rectal Tubes
|
5
|
|
|
|
Diazepam 10mg/2ml Inj
|
10
|
|
|
|
Diclofenac 100mg Suppositories
|
10
|
|
|
|
Epistatus 10mg/1ml oral syringes
|
4
|
|
|
|
Fentanyl 100 Patch (prescribe by brand as Mezolar)
|
1x5
|
|
|
|
Fentanyl 12 Patch (prescribe by brand as Mezolar)
|
1x5
|
|
|
|
Fentanyl 25 Patch (prescribe by brand as Mezolar)
|
1x5
|
|
|
|
Fentanyl 50 Patch (prescribe by brand as Mezolar)
|
1x5
|
|
|
|
Fentanyl 75 Patch (prescribe by brand as Mezolar)
|
1x5
|
|
|
|
Furosemide 40mg tablets
|
1 x 28
|
|
|
|
Glycopyrronium Bromide 200mcg/ml inj
|
20x1ml
|
|
|
|
Haloperidol 500mcg capsules
|
30
|
|
|
|
Haloperidol 5mg/ml inj
|
20x1ml
|
|
|
|
Hyoscine Butylbromide 20mg/ml inj (Buscopan)
|
20x1ml
|
|
|
|
Hyoscine 1.5mg patch
|
3x 2
|
|
|
|
Hyoscine Hydrobromide 400mcg/ml inj
|
10x1ml
|
|
|
|
Konakion MM 10mg/ml (Phytomenadione) Dose to be administered ORALLY is 2mg so appropriate syringes must be kept in stock too
|
10x1ml
|
|
|
|
Levomepromazine 25mg tablets
|
1x84
|
|
|
|
Levomepromazine (Methotrimeprazine) 25mg/ml inj
|
20x1ml
|
|
|
|
Lorazepam 1mg tablets
|
2x 28
|
|
|
|
Metoclopramide 10mg/2ml inj
|
10x2ml
|
|
|
|
Midazolam 10mg/2ml inj (Hypnovel)
|
10x5ml
|
|
|
|
Morphine sulphate 10mg/ml inj
|
20 x1ml
|
|
|
|
Morphine sulphate 15mg/ml inj
|
1x10
|
|
|
|
Morphine sulphate 30mg/ml inj
|
1x10
|
|
|
|
Morphine sulfate 10mg/5ml oral solution
|
2x300ml
|
|
|
|
Olanzapine 5mg Orodispersible tablets SF
|
2x 28
|
|
|
|
Ondansetron 8mg tablets
|
1x10
|
|
|
|
Oxycodone 10mg/ml 1ml inj
|
1x5
|
|
|
|
Oxycodone 10mg/ml 2ml inj (20mg/2ml)
|
1x5
|
|
|
|
Oxycodone liquid 5mg/5ml
|
1x250ml
|
|
|
|
Phenobarbital sodium 200mg/ml inj
|
10
|
|
|
|
Relenza 5mg inh powder blisters + inhaler
|
1x20 blisters
|
|
|
|
Tamiflu 6mg/ml oral suspension
|
1x65 ml
|
|
|
|
Tamiflu 75mg capsules
|
3x10
|
|
|
|
Sodium chloride 0.9% inj
|
20x10ml
|
|
|
|
Water for injection
|
20x10ml
|
|
|
|
Zomorph 10mg capsules
|
1x60
|
|
|
|
Zomorph 30mg capsules
|
1x60
|
|
|
|
|
|
.... |
Non Formulary Items |
Fentanyl
(Nasal Spray)

|
Non Formulary
|
|
|
Fentanyl
(lozenges)

|
Non Formulary
|
|
|
|
Key |
|
|
Cytotoxic Drug
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
High Cost Drug Approval System |
|
Traffic Light Status Information
|
|
|